AngioDynamics granted FDA prostate IDE approval for NanoKnife system
Neostem expands intellectual property protection to Canada around stem cell product AMR-001
We are still working out some issues with the Twitter functionality for our social media monitoring section, but should have it resolved shortly. We apologize for the incovenience.
Submit an article to cafepharma's CP Wire. Click here to find out more.
Company |
Average | Last 24h | Increase |
|---|---|---|---|
| Abbott Laboratories | 20 | 32 | 60 % |
| Akamai | 5 | 11 | 120 % |
| Alcon | 3 | 6 | 100 % |
| American Medical Alert | 26 | 43 | 65 % |
| Amgen | 6 | 10 | 67 % |
| Arana | 20 | 32 | 60 % |
| Arena Pharmaceuticals | 3 | 8 | 167 % |
| Ascent Healthcare Solutions | 4 | 9 | 125 % |
| Aspen | 31 | 49 | 58 % |
| Astellas | 1 | 6 | 500 % |